Results 51 to 60 of about 2,002,341 (191)

Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion

Case Reports in Oncology, 2020
Use of yttrium-90 (Y-90) is used for primary liver tumors and a handful of liver metastatic lesions. Y-90 treatment for metastatic adrenocortical carcinoma (ACC) to the liver is currently off-label, with one previously documented case report.
Nicholas Pigg, Daniel Aboubechara, Roberto Fourzali, Brian Baigorri   +3 more
doaj   +1 more source

Tumor Number and Model for End‐Stage Liver Disease Score as Selection Criteria for Resection or Embolization of Intermediate‐Stage Hepatocellular Carcinoma

Cancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Tumor and liver‐related factors are well‐known prognostic factors for patients with hepatocellular carcinoma (HCC). The Japanese Society of Hepatology (JSH) guidelines recommend considering liver resection (LR) for patients with multiple tumors and a tumor number ≤ 3.
Yi‐Hao Yen, Chee‐Chien Yong, Yueh‐Wei Liu, Wei‐Feng Li, Chih‐Chi Wang, Chih‐Yun Lin   +5 more
wiley   +1 more source

Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Analysis [PDF]

, 2020
PurposeTo report outcomes of yttrium-90 ( 90Y) radioembolization in patients with unresectable intrahepatic cholangiocarcinoma (ICC).Materials and MethodsRetrospective review was performed of 115 patients at 6 tertiary care centers; 92 were treated with ...
Weiss, MJ, Bell, Jon K., Sze, Daniel Y., Taylor, Kevin B, Taylor, Kevin B., Brown, Daniel B, Lamarca, Angela, Mahvash, Armeen, Hagendoorn, Jeroen, Borgmann, Anthony J, Braat, A, Groot Koerkamp, B; id_orcid, Weiss, Matthew J., Lam, Marnix G E H, Taylor, KB, Hagendoorn, J, Valle, Juan W, Lam, M, Borgmann, Anthony J., Braat, Arthur J.a.t., LaMarca, A, Braat, Arthur J A T, Bell, Jon K, Koerkamp, Bas Groot, Kappadath, SC, Buettner, Stefan, Valle, JW, Margonis, Georgios Antonios, Valle, Juan W., Ijzermans, Jan N.m., Groot Koerkamp, B, Brown, Daniel B., Bell, JK, Sze, Daniel Y, Mahvash, A, Lam, Marnix G.e.h., Kappadath, S. Cheenu, IJzermans, J.N.M., Kappadath, S Cheenu, Borgmann, AJ, Weiss, Matthew J, Buttner, Stefan, Margonis, GA, Brown, DB, IJzermans, Jan N M, Sze, DY   +45 more
core   +1 more source

Advances and challenges in immunotherapy for intrahepatic cholangiocarcinoma based on the tumour immune microenvironment

Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.
This review integrates ICC‐specific and broader BTC evidence to define how desmoplastic stroma, immune‐cell crosstalk, metabolic remodelling, and molecular heterogeneity shape immunotherapy response and resistance. It highlights biomarker‐guided, mechanism‐based combinations while emphasizing the limited maturity of ICC‐specific evidence for emerging ...
Mengyao Chen, Shuofan Jin, Yuxuan Zhou, Jinkai Tong, Yufan Zhao, Quanjun Yang   +5 more
wiley   +1 more source

Radioembolization Treatment for Liver Cancer

Bezmiâlem Science, 2016
Although curative treatment is surgery (resection/transplantation) and for small lesions ablative strategies, in primary liver carcinomas such as hepatocellular carcinoma and cholangiocellular carcinoma, palliative treatment is used for most of these ...
Ezgi Başak ERDOĞAN, Hüseyin ÖZDEMİR, Mehmet AYDIN   +2 more
doaj   +1 more source

Radiotherapy and Immunotherapy In Hepatocellular Carcinoma: Priming the Tumor Immune Microenvironment From Bench To Bedside

Precision Radiation Oncology, Volume 10, Issue 3, Page 417-427, September 2026.
The dual immunomodulatory network of radiotherapy in hepatocellular carcinoma. Radiotherapy initiates its effects by inducing immunogenic cell death and DNA double‐strand breaks. Immune Activation: Cytosolic DNA from damaged cells activates the cGAS‐STING pathway, triggering IRF3/NF‐κB‐mediated type I interferon production. This enhances dendritic cell
Zhigang Fu, Yang Zhang, Zuomin Wang, Zongjuan Li, Shisuo Du   +4 more
wiley   +1 more source

Management of Satellite Lesions in Hepatocellular Carcinoma: An Updated Review

Journal of Surgical Oncology, Volume 134, Issue 2, Page 157-165, August 2026.
ABSTRACT Satellite lesions, defined as microscopic or small macroscopic tumor nodules within 2 cm of a primary hepatocellular carcinoma (HCC), represent early intrahepatic dissemination and are strongly associated with aggressive tumor biology.
Andy Tran, Mohammed O. Suraju, Ihuoma Tasie, Abdelrahman K. Abdalla, Hassan Aziz   +4 more
wiley   +1 more source

Internal dosimetry of non-uniform activity distributions: a simple method for the calculation of the absorbed dose distribution at voxel level in radionuclide therapy [PDF]

, 2013
Internal dosimetry of non-uniform activity distributions: a simple method for the calculation of the absorbed dose distribution at voxel level in radionulcide therapy Radiotherapy is the medical use of ionizing radiations to control or kill clonogenic ...
AVIGO, CINZIA
core   +1 more source

AAPM Medical Physics Practice Guideline 14.a: Yttrium-90 microsphere radioembolization [PDF]

Radioembolization using Yttrium-90
et al.,, Maughan, Nichole M, Busse, Nathan C   +2 more
core   +1 more source

Highlighting survival with yttrium-90 radioembolization therapy in unresectable hepatocellular carcinoma

, 2020
Unresectable hepatocellular carcinoma has several different therapeutic options, including targeted agents as well as locoregional therapy. Yttrium-90 (Y90) radioembolization therapy is an established treatment for unresectable disease and has been ...
James, Edward, Nabrinsky, Edward
core   +1 more source